Aigen Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,917
Closed -$861K 713
2025
Q4
$861K Buy
+16,917
New +$865K 0.2% 142
2025
Q2
Sell
-34,284
Closed -$2.38M 989
2025
Q1
$2.38M Buy
34,284
+25,769
+303% +$2.13M 0.38% 58
2024
Q4
$732K Buy
8,515
+6,023
+242% +$651K 0.13% 233
2024
Q3
$297K Buy
+2,492
New +$332K 0.06% 476
2024
Q2
Sell
-6,979
Closed -$896K 949
2024
Q1
$896K Sell
6,979
-182
-3% -$21.7K 0.2% 160
2023
Q4
$741K Buy
+7,161
New +$708K 0.13% 223
2023
Q3
Sell
-17,904
Closed -$1.45M 1001
2023
Q2
$1.45M Buy
+17,904
New +$1.46M 0.21% 133
2022
Q3
Sell
-9,846
Closed -$549K 700
2022
Q2
$549K Buy
+9,846
New +$546K 0.09% 287
2022
Q1
Sell
-20,154
Closed -$1.08M 915
2021
Q4
$1.08M Buy
20,154
+15,596
+342% +$845K 0.07% 392
2021
Q3
$219K Buy
+4,558
New +$220K 0.04% 403

Other funds holding NVO